FDA Panel Urges Removal of Black Box Warning for Low-Dose Hormone Therapy
A panel of doctors has urged the FDA to remove black box warning labels from low-dose estrogen treatments, citing that they are not supported by science and may be deterring women from using beneficial medication. The label warnings, which include increased risks of endometrial cancer, cardiovascular disorders, probable dementia, and breast cancer, have been in … Read more